Bridget Quinn, MD
Attending Physician, Orthopedics and Sports Medicine Department; Company Physician, Boston Ballet; Lead Consulting Physician, Dean College Palladino School of Dance & Performing Arts
Assistant Professor of Orthopedics, Harvard Medical School
Image
Bridget Quinn, MD
Attending Physician, Orthopedics and Sports Medicine Department; Company Physician, Boston Ballet; Lead Consulting Physician, Dean College Palladino School of Dance & Performing Arts
Assistant Professor of Orthopedics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
University of Vermont
2001
Burlington
VT
Medical School
University of Vermont
2005
Burlington
VT
Residency
Emergency Medicine
Emory University
2008
Atlanta
GA
Fellowship
Sports Medicine
Boston Children's Hospital
2009
Boston
MA
Media
Answers Blog
When athletes push too hard: How to screen and when to refer
Answers Blog
Nurturing strength: Tips for parents of female athletes
Certifications
American Board of Emergency Medicine (General)
Publications
Relationship Between Sport Specialization and Quality of Life in Young Female Dancers. View Abstract
Quality of Life Measures in Young Pre-Professional Dancers Compared to Non-Athletes and Non-Dancer Athletes. View Abstract
Platelet rich plasma for hallux sesamoid injuries: a case series. View Abstract
Hallux Sesamoid Injury Characteristics in Young Athletes Presented to the Sports Medicine Clinic. View Abstract
Special Considerations for Growing Dancers. View Abstract
Part II: Comparison of Crossfit-Related Injury Presenting to Sports Medicine Clinic by Sex and Age. View Abstract
Part I: Crossfit-Related Injury Characteristics Presenting to Sports Medicine Clinic. View Abstract
The Evaluation of Strength, Flexibility, and Functional Performance in the Adolescent Ballet Dancer During Intensive Dance Training. View Abstract
Body Mass Index and Menstrual Patterns in Dancers. View Abstract
Physical Activity Level and Symptom Duration Are Not Associated After Concussion. View Abstract
Athletes Doing Arabesques: Important Considerations in the Care of Young Dancers. View Abstract
"Nutcracker Fracture" in a Ballet Dancer Performing in The Nutcracker. View Abstract
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells. View Abstract
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. View Abstract
Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. View Abstract
The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocarcinoma. View Abstract
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic. View Abstract
Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach. View Abstract
Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. View Abstract
Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV). View Abstract
Targeting the Bcl-2 family for cancer therapy. View Abstract
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. View Abstract
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells. View Abstract
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. View Abstract
Targeting Mcl-1 for the therapy of cancer. View Abstract
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. View Abstract
Development of a syngeneic mouse model of epithelial ovarian cancer. View Abstract
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. View Abstract
Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. View Abstract
Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. View Abstract
Locations